Skip to content
HowShorted

4D Molecular Therapeutics, Inc. short interest in 2026

In 2026, 4D Molecular Therapeutics, Inc.'s disclosed short interest ran from 14.01% of shares outstanding on 15 Jan 2026 to 16.64% on 15 Sep 2026, a change of +2.63 percentage points. The year's high was 19.22% on 30 Jun 2026 and its low 13.72% on 30 Jan 2026, averaging 16.48% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 22.32 days on 14 Aug 2026. Full history: 4D Molecular Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for 4D Molecular Therapeutics, Inc. in 2026

2026 in figures

Start of year
14.01% (15 Jan 2026)
End of year
16.64% (15 Sep 2026)
Change
+2.63 pp
High
19.22% (30 Jun 2026)
Low
13.72% (30 Jan 2026)
Average
16.48%
Highest days to cover
22.32 (14 Aug 2026)
SEC filings marked
7

Every report in 2026

4D Molecular Therapeutics, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202614.01%11.22results (8-K)
30 Jan 202613.72%13.28
13 Feb 202614.37%13.01
27 Feb 202614.98%15.11
13 Mar 202615.37%14.13
31 Mar 202615.98%12.1210-K filed, results (8-K)
15 Apr 202616.94%16.29
30 Apr 202617.64%17.90
15 May 202617.46%19.0810-Q filed, results (8-K)
29 May 202617.62%13.97
15 Jun 202618.68%16.53
30 Jun 202619.22%9.10
15 Jul 202616.42%15.51
31 Jul 202617.39%17.69
14 Aug 202617.03%22.3210-Q filed, results (8-K)
31 Aug 202616.72%8.15
15 Sep 202616.64%18.55

See also: 4D Molecular Therapeutics, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.